Turning EAP Data into Action: Applying Insights to Regulatory & Access Strategy
- Differentiating how EAP data complements clinical trial outcomes
- Understanding how EAP data is being used to support regulatory dialogue and submissions
- Integrating real-world insights into broader evidence-generation and access planning
- Demonstrating how RWD collected through EAPs is used to inform pricing, reimbursement decisions, and negotiations with health authorities, backed by realworld case studies